ServiziMenu principaleHome
You are here:  > Educational Opportunities > Past events > 2019 > 18th ESO-ESMO Masterclass in Clinical Oncology
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

18th ESO-ESMO Masterclass in Clinical Oncology

30 ESCO credits

23.03.2019  -  28.03.2019

Nauen OT Gross Berhnitz (Berlin area)


Medical / clinical oncology


Chairs: N. Pavlidis, GR - R.A. Stahel, CH
Scientific Advisors: F. Lordick, DE - R. Popescu, CH

This clinically oriented educational programme has been designed for medical or clinical oncologists who wish to improve their skills or those who are preparing for the national board exam.
The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-oriented training. The programme focuses on breast, colorectal, lung, genito-urinary, gynaecological, head and neck cancers.
Spotlight sessions will facilitate compact update on mentorship, cancer of unknown primary, immuno-oncology, low and high grade lymphomas, neuro-endocrine tumours, case based management of sarcomas, molecular tumour boards, melanoma, supportive and palliative care, mind body medicine, burn-out syndrome, basic public speaking and developments in liquid biopsy in oncology.

The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will conclude in take-home messages. Participants will deliver case presentations within tumour boards and small groups and discuss them with the chairmen and the faculty. Informal discussion will be facilitated during the lunches and the aperitifs with the experts.
All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and fluency in English is necessary for admission. Participants of the concomitant Masterclass in Nursing Oncology will attend selected medical sessions whilst the communication skills sessions will be attended jointly.

• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering lectures focusing on genito-urinary, breast, gynaecological, head and neck, gastro-intestinal and lung cancers.

The Masterclass in
Clinical Oncology is an
ESO-ESMO joint event


The Masterclass is held
in collaboration with the
Flims Alumni Club


The 2019 Masterclass is part of
the Masterclass-Online Study
Program in Advanced Oncology
of the University of Ulm




FACULTY (as of September 2018)
M. Aapro, Clinique de Genolier, Oncology Dpt., Genolier, CH
A. Arber, University of Surrey, Faculty of Health and Medical Sciences, Guildford, UK
S. Banerjee, The Royal Marsden NHS Trust Foundation, Dept. of Gynaeclogy, London, UK
P. Casali
, National Cancer Institute, Medical Oncology Dpt., Milan, IT

G. Curigliano, European Institute of Oncology, Department of Medicine, Division of Experimental Therapeutics, Milano, IT
U. Dafni, Centre Hospitalier Universitaire Vaudois, Dept. of Oncology, Lausanne, CH
J. De Munter
, University Hospital Ghent, Oncology Dpt., Ghent, BE
M. De Santis
, Charité University Hospital, Urology Clinic, Berlin, DE
A. Dietz
, University Hospital Leipzig, ENT Department, Leipzig, DE

M. Dreyling, Munich University Hospital, Medical Clinic III, Munich, DE
A. Eniu, Cancer Institute "Ion Chiricuta", Dept. of Breast Cancer, Cluj-Napoca, RO
K. Fizazi, Institut Gustave Roussy, Dept. of Cancer Medicine, Villejuif, FR
W. Gatzemeier, Humanitas Cancer Center, Breast Unit, Rozzano, IT
D. Hart, Cameron Communications, London, UK
S. Hillinger, University Hospital Zurich, Thoracic Surgery Dpt., Zurich, CH
A. Hoy
, Consultant in Palliative Medicine, Epsom, UK

F. Lordick, University Hospital Leipzig, University Cancer Center Leipzig, Leipzig, DE
F. Mc Donald, The Royal Marsden NHS Foundation Trust, Dept. of Radiotherapy, London, UK
O. Michielin, Lausanne University Hospital - CHUV, Dept. of Medical Oncology, Lausanne, CH
R. Orecchia, European Institute of Oncology, Div. of Radiotherapy, Milan, IT
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Breast Unit, Bellizona, CH
N. Pavlidis, University Hospital of Ioannina, Div. of Medical Oncology, Ioannina, GR
R. Popescu, Hirslanden Klinik Aarau, Tumor Center - Dept. of Medical Oncology, Aarau, CH
G. Pruneri, University of Milan – European Institute of Oncology, Dept. of Pathology - Biobank for Translational Medicine Dpt., Milano, IT
M. Schumacher, Hirslanden Klinik Aarau, Dept. of Urology, Aarau, CH
J. Sehouli, Charité Medical University, Gynaecological Clinic, Berlin, DE
C. Sessa, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona, CH
R. Stahel, University Hospital Zurich, Cancer Center Zurich, Zurich, CH
C. Toumpanakis, Royal Free Hospital, Centre for Gastroenterology, London, UK
E. Van Cutsem, University Hospital Leuven, Digestive Oncology Dpt., Leuven, BE
R. Verity, King's College London, Florence Nightingale Faculty of Nursing and Midwifery, London, UK
J.B. Vermorken, Antwerp University Hospital, Dept. of Medical Oncology, Edegem, BE
P. Vlummens, University Hospital Ghent, Oncology Dpt., Ghent, BE
J. Weitz, University Hospital Carl Gustav Carus, Dept. of Visceral, Thoracic and Vascular Surgery, Dresden, DE
M. Weller, University Hospital Zurich, Dept. of Neurology, Zurich, CH
H. Wikman, university Hospital Hamburg-Eppendorf, Center for Experimental Medicine, Hamburg, DE
C. Witt, University Hospital Zurich and University of Zurich, Inst. Complementary and Integrative Medicine, Zurich, CH

General information

ORGANISING SECRETARIAT                       
Francesca Marangoni                            
Ph: +39 02 85464525                           
Email: fmarangoni@eso.net                        
European School of Oncology
Via Turati, 29
20121 Milan, Italy
Fax: +39 02 85464545

Corinne Hall
Ph: +39 02 85464522
Email: chall@eso.net


Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the applications can be obtained from the organising secretariat.
The Masterclass has also been accredited with 25 Cat.1 ESMO MORA points.

The Masterclass is part of the Sharing Progress in Cancer Care programme whose sustaining members are (as of June 2018):
Platinum member: Astrazeneca, BMS
Gold members: Eli Lilly, Helsinn, Pfizer
Silver members: Amgen, Celgene Corporation, Genomic Health, Novartis Oncology, Sandoz Biopharmaceutical, Takeda Pharmaceuticals International AG

Follow updates, send questions and join in the discussions using #19MCO on Twitter and Facebook.


Application deadline: 01 December 2018  
Save event date: 23 March 2019  



• Age between 30 and 40 years
• At least 2-3 years’ experience in medical oncology or clinical oncology
• Involvement in scientific activities
• Fluency in English

Successful applicants are granted free registration and accommodation



23 March

    Participants' arrival, airport transfers, registration
 13:00   Lunch      
 14:00   Focus on ESO, ESMO and EONS
N. Pavlidis, GR - R. Stahel, CH - R. Verity, UK
14:30   Communication Skills Workshop - 2 Groups
A. Arber, UK - A. Hoy, UK       
14:30   Warm up + Case presentations by participants - 2 Groups
R. Popescu, CH - R.A. Stahel, CH
  Coffee break
17:00   Communication Skills Workshop - 2 Groups 
A. Arber, UK - A. Hoy, UK
  Warm up + Case presentations by participants - 2 Groups
F. Lordick, DE - N. Pavlidis, GR
20:00   Dinner    


 24 March

 8:15   Clinical session Lung cancer   
Chair: R.A. Stahel, CH
S. Hillinger, CH   
F. Mc Donald, UK
Chemotherapy and targeted treatment    
R.A. Stahel, CH
Immunotherapy of thoracic malignancies   
R.A. Stahel, CH
Small cell lung cancer   
F. Mc Donald, UK
General discussion   
11:00   Coffee break  
 11:30   Tumour board Lung cancer    
R.A. Stahel, CH - F. Mc Donald, UK - S. Hillinger, CH
 12:30   Spotlight session Mentorship   
R.A. Stahel, CH      
 13:00   Lunch with the expert
 14:00   Spotlight session Cancer of unknown primary   
N. Pavlidis, GR
 14:30   Spotlight session Case based management of issues in immuno-oncology
R.A. Stahel, CH
 15:10   Spotlight session Low and high grade lymphomas: recent therapeutic advances
M. Dreyling, DE
 15:50   Case presentations by participants (4 groups)
F. Lordick, DE - N. Pavlidis, GR - R. Popescu, CH - R.A. Stahel, CH
 18:30   Networking Aperitif
 19:30   Dinner


 25 March

  Clinical session Gastro-intestinal tumours   
Chair: E. van Cutsem, BE  
    Systemic treatment in early and advanced gastric cancer   
F. Lordick, DE     
Pancreatic cancer   
R. Popescu, CH
Management of rectal cancer (surgery and radiotherapy)   
J. Weitz, DE
Systemic treatment in adjuvant setting in colon cancer   

E. van Cutsem, BE     
Systemic treatment in advanced colon cancer    
E. van Cutsem, BE
10:45   Coffee break         
    Contribution of surgery on stage IV colon cancer
J. Weitz, DE
    General discussion
12:00   Tumour board Gastro-intestinal tumours    
F. Lordick, DE - R. Popescu, CH - E. van Cutsem, BE
13:00   Lunch with the expert
14:00   Spotlight session Burn-out syndrome
S. Banerjee, UK
14:30   Spotlight session Case-based management of supportive and palliative care
M. Aapro, CH    
 15:00   Spotlight session Molecular tumour boards
O. Michielin, CH
15:40   Spotlight session Melanoma
O. Michielin, CH
 18:30   Networking Aperitif      


 26 March

8:15   Clinical session Breast cancer (early and advanced)   
Chair: G. Curigliano, IT  
G. Pruneri, IT    
W. Gatzemeier, IT
R. Orecchia, IT      
Treatment of Luminal    
O. Pagani, CH
Treatment of HER-2+
A. Eniu, RO      
10:40   Coffee break        
    Treatment of triple negative   
G. Curigliano, IT
General discussion
12:00   Tumour board Breast cancer    
G. Curigliano, IT - O. Pagani, CH - W. Gatzemeier, IT - A. Eniu, RO - G. Pruneri, IT - R. Orecchia, IT
13:00   Lunch with the expert
14:00   Spotlight session Case based management of soft tissue sarcomas
P. Casali, IT
14:45   Spotlight session Essentials in biostatistics
U. Dafni, CH   
15:15   Spotlight session Mind body medicine
C. Witt, CH
15:45   Clinical case presentation by a doctor and a nurse
P. Vlummens, BE - J. De Munter, BE
 16:20   Discussion
16:30   Spotlight session Neuro-endocrine tumours
C. Toumpanakis, UK
 18:30   Networking Aperitif    
 19:30   Dinner + special evening    


 27 March

8:15   Clinical session Genito-urinary cancers   
Chair: K. Fizazi, FR
    Localized prostate cancer   
M. Schumacher, CH
Treatment of metastatic castration sensitive prostate cancer   
K. Fizazi, FR      
Castration-resistant prostate cancer   
K. Fizazi, FR      
Metastatic renal cancer: evidence-based treatment   
M. De Santis, DE  
Treatment of bladder cancer
M. De Santis, DE
General discussion                  
10:45   Coffee break
11:15   Tumour board Genito-urinary cancers    
K. Fizazi, FR - R. Orecchia, IT - M. Schumacher, CH
12:15   Spotlight session Basic public speaking
D. Hart, UK
13:00   Lunch with the expert
 14:00   Clinical session Head and neck cancer   
Chair: Jan B. Vermorken, NL
    Prognostic factors and surgical approach  
A. Dietz, DE     
R. Orecchia, IT
Systemic therapy and radio- chemo-therapy   
J.B. Vermorken, NL
General discussion

 16:00   Tumour board Head & Neck cancer
A. Dietz, DE - R. Orecchia, IT - J.B. Vermorken, NL
16:30   Spotlight session Brain tumours
M. Weller, CH
18:30   Networking Aperitif
19:30   Dinner


 28 March

 8:15   Clinical session Gynaecological cancers   
J.B. Vermorken, BE
J. Sehouli, DE
Ovarian cancer   

J.B. Vermorken, BE
Cervical and endometrial cancers
C. Sessa, CH
General discussion
10:30   Coffee break
 11:00   Tumour board Gynaecological cancers (2 cases)
J.B. Vermorken, DE - C. Sessa, CH
11:30   Learning Assessment Test
 12:30   Keynote session Developments in liquid biopsy in oncology
H. Wikman, DE
 13:00   Closing remarks